Mesoblast will implement Medidata Solutions cloud-based platform, Medidata Rave along with Rave Safety Gateway, Rave Targeted SDV and Medidata Coder across its clinical studies.
The technologies are expected to support the development of treatments based on Mesoblast’s proprietary adult stem cell technology.
Medidata Rave, which is a electronic data capture(EDC) and clinical data management (CDM) solution enables visibility into clinical trial data while Rave Targeted SDV is expected to reduce site monitoring costs through a risk-based approach.
The further selected Rave Safety Gateway and Medidata Coder technologies will increase the efficiency of its safety reporting process, according to Medidata Solutions.
Medidata Solutions CEO Tarek Sherif said, "We’re very excited that the Medidata Clinical Cloud is playing a key role in allowing Mesoblast to execute at the forefront of regenerative medicine research and adult stem cell technology."